Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI	Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, disease arising from reactivation of latent virus, gram-positive bacterial infections, latent tuberculosis infection, mycobacterial infectious disease, tuberculosis	Recruiting	Phase 2 / Phase 3	2026-05-06		NCT03474029

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Centers for Disease Control and Prevention	84

21 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
British Columbia Centre for Disease Control	Vancouver	Canada	1
Calgary TB Clinic	Calgary	Canada	1
Denver Health and Hospital Authority	Denver	United States	11
Desmond Tutu TB Center	Stellenbosch	South Africa	1
Edmonton TB Clinic	Edmonton	Canada	1
George Washington University	Washington D.C.	United States	1
Ho Chin Minh City-District 6 TB Unit	Ho Chi Minh City	Vietnam	1
Ho Chin Minh City-Phoi Viet Resportory Centre	Ho Chi Minh City	Vietnam	1
Joint Clinical Research Centre/ Makerere Univ Med Sch	Kampala	Uganda	1
Les Centres Gheskio (INLR) CRS	Port-au-Prince	Haiti	1
Liverpool Hospital	Sydney	Australia	3
McGill University Health Centre	Montreal	Canada	2
National Referral University Hospital for Pneumo-physiology	Cotonou	Benin	1
New York City Bureau of TB Control	New York	United States	1
New York Harbor Healthcare System	Manhattan	United States	1
Paramatta Chest	Sydney	Australia	1
Royal Prince Alfred Hospital	Sydney	Australia	6
San Antonio VA	San Antonio	United States	1
Seattle King County Health Department	Seattle	United States	1
Toronto Western Hospital	Toronto	Canada	1
Washington DC VA Medical Center	Washington D.C.	United States	1

Clinical trials